TDMR Europe – ‘Reducing future risk: Obesity co-morbidities and nutritional status’ – INDEX PAGE
Posted On: 4th August 2020
Total Diet & Meal Replacements Europe (TDMR Europe)’s webinar, ‘Reducing future risk: Obesity co-morbidities and nutritional status’, attracted over 100 academics, policymakers and medical specialists from all over the world.
The webinar, which had been awarded SCOPE World Obesity Federation accreditation, highlighted the use of total diet replacements to reduce future risk of diabetes and cardiovascular disease and diminish severe outcomes in COVID-19 among at-risk subgroups within populations. The speakers discussed a range of diverse and challenging topics, including obesity, nutritional status and COVID-19, TDR to achieve diabetes remission and diabetes risk reduction, TDR and vitamin D status in elderly obese people with knee osteoarthritis, and research needs and translation into practice in the context of diabetes remission.
Please follow the link to each individual presentation:
Reducing future risk: Obesity co-morbidities and nutritional status
Introduction by Anthony R Leeds, Chairman of TDMR Europe, University of Copenhagen and IMU, Malaysia
– Carel le Roux, University College Dublin
– Mike Lean, University of Glasgow
– Henning Bliddal, Parker Institute, Frederiksberg Hospital, Copenhagen
– Shahrad Taheri, Weill Cornell Medicine Qatar
TDMR Europe represents the voice of European manufacturers and distributors of formula diet products, including Total Diet Replacements (TDRs) and Meal Replacement Products (MRPs), that provide weight loss and weight management programmes for overweight and obese individuals.
If you would like to contact TDMR Europe to discuss the webinar or any other matter, email firstname.lastname@example.org.